Clinical Trial on Pharmacokinetic and Tolerability of AP701
NCT04708795
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Pharmacokinetic
Tolerability
Safety
Interventions
DRUG:
AP701
Sponsor
CannaXan GmbH